Social environment as a modulator of immunosenescence.

Aging homeostatic systems immunosenescence loneliness social environment social strategy stress response

Journal

Expert reviews in molecular medicine
ISSN: 1462-3994
Titre abrégé: Expert Rev Mol Med
Pays: England
ID NLM: 100939725

Informations de publication

Date de publication:
01 08 2022
Historique:
pubmed: 2 8 2022
medline: 24 8 2022
entrez: 1 8 2022
Statut: epublish

Résumé

Immune system aging, a process known as immunosenescence, involves a striking rearrangement affecting all immune cells, resulting in an increased rate of infections and a major incidence of autoimmune diseases and cancer. Nonetheless, differences in how individuals of the same chronological age carry out this immunosenescence establishment and thus the aging rate have been reported. In the context of neuroimmunoendocrine communication and its role in the response to stress situations, growing evidence suggests that social environments profoundly influence all physiological responses, especially those linked to immunity. Accordingly, negative contexts (loneliness in humans/social isolation in rodents) were associated with immune impairments and decreased lifespan. However, positive social environments have been correlated with adequate immunity and increased lifespan. Therefore, the social context in which an individual lives is proposed as a decisive modulator of the immunosenescence process and, consequently, of the rate of aging. In this review, the most important findings regarding how different social environments (negative and positive) modulate immunosenescence and therefore the aging rate, as well as the role of stress responses, hormesis, and resilience in these environments will be explained. Finally, several possible molecular mechanisms underlying the effects of negative and positive environments on immunosenescence will be suggested.

Identifiants

pubmed: 35912691
doi: 10.1017/erm.2022.24
pii: S1462399422000242
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e29

Auteurs

A Garrido (A)

Department of Immunology and Oncology, National Centre for Biotechnology (CNB), Spanish Research Council (CSIC), Madrid, Spain.

I Martínez de Toda (I)

Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain.
Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain.

E Díaz Del Cerro (E)

Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain.
Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain.

J Félix (J)

Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain.
Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain.

N Ceprián (N)

Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain.
Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain.

M González-Sánchez (M)

Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain.
Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain.

M De la Fuente (M)

Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain.
Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH